Case report reveals invasive chronic rhinosinusitis caused by Bjerkandera adusta successfully treated with voriconazole, indicating rare fungal infection risks in immunodeficient individuals.
We report an invasive mycosis case in Japan caused by Bjerkandera adusta, a fungal species not previously reported as a causative pathogen of invasive mycosis. B. adusta was identified by using phylogenetic analysis. Voriconazole was used successfully for treatment. Immunodeficient patients may be susceptible to infection by rare causative fungi.
No takes yet. Share an insight, caveat, or question.
Kurata et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: